Rua Bioscience has almost doubled its full-year loss as it works towards becoming a revenue-generating business.
The NZX-listed medical cannabis business posted a loss of $8.6 million for the 12 months ended June 30, down from a $4.4m loss in its 2021 financial year.
The business generated more
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
